Opioid use in pregnancy linked to childhood illness According to new research, women who used opioids during pregnancy are more likely to have children with infections, eczema and asthma later in life.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
New chronic cough advice ‘well worth bookmarking’ A ‘comprehensive’ update to chronic cough advice suggests child‐specific management will improve clinical outcomes.
Ventolin nebules shortage flagged A shortage of the 2.5 mg/2.5 mL salbutamol inhalation solution ampoule is expected from mid next week until August 2024.
‘Fever phobia’ and the role of the GP A recent poll found that many parents mistakenly believe that fevers in children can cause significant harms if left untreated.
Future asthma risk flagged for babies with food allergy Even if the allergy is outgrown, poorer lung function outcomes are more likely by six years of age, a world-first study finds.
‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.
First RSV vaccine approved in US The US drugs regulator has given the green light to a new vaccine, which is also under consideration by the TGA in Australia.
Possible RSV vaccine is ‘very exciting’ Given to pregnant women, the RSV vaccine is shown to prevent severe disease for up to the first six months of life.
In Practice: Managing tick-borne illnesses The information is aimed to further support health professionals and patients to better understand tick-borne illness in Australia.